. Author manuscript; available in PMC: 2011 Apr 25.

Published in final edited form as: Am J Med Genet B Neuropsychiatr Genet. 2009 Oct 5;150B(7):926–933. doi: 10.1002/ajmg.b.30919

Table V. Association With SymAlcAD and SymCanAD in the Combined Sample^a.

	Marker	Allele	Count	Frequency	Effect	95% CI low bound	95% CI high bound	Chi square	P-value
SymAlcAD (1,801)	rs684513	G	737	0.207	-	-	-	2.68	0.1019
	rs16969968	G	2,350	0.662	0.224	0.060	0.387	7.23	0.0072
	rs578776	A	967	0.273	-	-	-	2.56	0.1093
	rs1051730	G	2,359	0.665	0.231	0.067	0.395	7.65	0.0057
	rs2869546	C	1,356	0.387	-	-	-	1.92	0.1655
	rs6495308	C	785	0.221	-	-	-	1.98	0.1594
	rs8192475	C	196	0.055	-	-	-	0.13	0.7197
SymCanAD (614)	rs684513	G	268	0.220	-	-	-	0.02	0.8870
	rs16969968	G	823	0.678	-	-	-	0.51	0.4769
	rs578776	A	338	0.280	-	-	-	0.67	0.4122
	rs1051730	G	832	0.684	-	-	-	0.51	0.4763
	rs2869546	C	472	0.393	-	-	-	0.01	0.9412
	rs6495308	C	286	0.235	-	-	-	0.18	0.6732
	rs8192475	C	61	0.051	-	-	-	0.00	0.9784

The effect sizes were shown for only those markers with a P-value less than 0.1. P-values ≤0.05 were in bold.

Table V. Association With SymAlcAD and SymCanAD in the Combined Samplea.